Partner Liane Peterson was quoted in a Bloomberg Law article, “Rush for Generic Go-Ahead on Novel Drugs Roils Pharma Industry,” about the growth in the number of generic drugmakers seeking to bring competing versions of brand name products to market as quickly as possible.
Peterson said the trend has led to more smaller players jumping in to be first-filers on profitable drugs, which “would suggest the bigger players don’t want to share the market with anyone else.”
People
Related News
13 January 2025
In the News
Matthew Krueger Assesses Government Health Care Enforcement Focuses for 2025
Foley & Lardner LLP partner Matthew Krueger assessed several key government health care enforcement targets for the year ahead in the Report on Medicare Compliance article, "Outlook 2025: Look for MA Cases Based on Claim Denials; Incoming DOJ May Tweak Guidance," published by the Health Care Compliance Association.
13 January 2025
In the News
Aaron Maguregui on HHS Cybersecurity Revamp – 'Going to be added costs across the board'
Foley & Lardner LLP partner Aaron Maguregui assessed the U.S. Department of Health and Human Services' (HHS) proposed overhaul of its cybersecurity rules in the Bloomberg Law article, "Health Supply-Chain Hacks Targeted by HHS Cybersecurity Rule."
13 January 2025
In the News
Judith Waltz Describes Potential Health Policy Changes Under New Administration
Foley & Lardner LLP partner Judith Waltz commented on potential health policy changes under the incoming presidential administration in the Report on Medicare Compliance article, "Outlook 2025: Disruption Is Expected, Along With More OIG Guidance, Payment Changes," published by the Health Care Compliance Association.